BeginNGS is a novel health care delivery system designed to screen newborns for genetic diseases — and connect their doctors with effective treatment options.
Welcome @Begin_NGS founding consortium member @sanofi. For 40 yrs, Sanofi has been a pioneer of science & innovation, rallying its people & resources to help improve the lives of those living with #RareDisease. We thank Sanofi for its #BeginNGS support.
sanofi.com/en/your-health/sp…
Today we’re excited to announce our new partnership with @Plumcare to support @BeginNGS_Greece & @RadyGenomics in Greece's new national pioneering newborn sequencing program. bit.ly/3GS29Zb
The annual Frontiers in Pediatric Genomic Medicine Conference is back, both in person and online. This year's theme is "Taking Steps Towards Ending the Diagnostic Odyssey." Mark your calendars for April 19-20, 2023. Registration opens in February. radygenomics.org/frontiers-c…
ICYMI: Dr. Stephen Kingsmore & Catherine Nester of @inozyme were guests on the #RareDisease Report podcast. They discussed the role of #newbornscreening in diagnosing rare diseases the impact @Begin_NGS can have on the future of rare disease medicine. hcplive.com/view/rare-diseas…
Thank you to @combined_brain for its support @Begin_NGS. COMBINEDBrain is a non-profit consortium devoted to speeding the path to clinical treatments for people with severe rare genetic, non-verbal, neurodevelopmental disorders.
#RareDisease#BeginNGScombinedbrain.org/
A new article from Dr. Stephen Kingsmore shares the urgent need for extensive expansion of #NewbornScreening by genomic sequencing, the reasons why early attempts had limited success & how we're working to end the diagnostic & therapeutic odysseys. onlinelibrary.wiley.com/doi/…
We've announced our membership to the @Begin_NGS consortium to help improve #NewbornScreening. Eric Crombez, MD, Chief Medical Officer for Gene Therapy at Ultragenyx, shares his perspective on the importance of this program. Read the blog post: ultragenyx.co/3C7XD6l